"Myocardial Ischemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
Descriptor ID |
D017202
|
MeSH Number(s) |
C14.280.647 C14.907.585
|
Concept/Terms |
Myocardial Ischemia- Myocardial Ischemia
- Ischemia, Myocardial
- Ischemias, Myocardial
- Myocardial Ischemias
- Ischemic Heart Disease
- Heart Disease, Ischemic
- Disease, Ischemic Heart
- Diseases, Ischemic Heart
- Heart Diseases, Ischemic
- Ischemic Heart Diseases
|
Below are MeSH descriptors whose meaning is more general than "Myocardial Ischemia".
Below are MeSH descriptors whose meaning is more specific than "Myocardial Ischemia".
This graph shows the total number of publications written about "Myocardial Ischemia" by people in this website by year, and whether "Myocardial Ischemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 1 | 0 | 1 |
1994 | 2 | 2 | 4 |
1995 | 1 | 0 | 1 |
1996 | 0 | 1 | 1 |
1997 | 2 | 0 | 2 |
1998 | 3 | 0 | 3 |
1999 | 1 | 1 | 2 |
2000 | 3 | 0 | 3 |
2001 | 1 | 1 | 2 |
2002 | 1 | 1 | 2 |
2003 | 3 | 0 | 3 |
2005 | 3 | 1 | 4 |
2007 | 2 | 0 | 2 |
2008 | 1 | 1 | 2 |
2009 | 1 | 1 | 2 |
2010 | 2 | 1 | 3 |
2011 | 1 | 0 | 1 |
2012 | 2 | 0 | 2 |
2013 | 0 | 1 | 1 |
2014 | 4 | 1 | 5 |
2015 | 1 | 1 | 2 |
2016 | 4 | 0 | 4 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
2021 | 1 | 0 | 1 |
2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myocardial Ischemia" by people in Profiles.
-
Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2023 Mar; 66(2):493-506.
-
Spontaneous thrombus formation in native aortic root in patients with hypoplastic left heart syndrome: clinical presentation, treatment, and outcomes. Cardiol Young. 2022 Aug; 32(8):1330-1332.
-
Treating Myocardial Ischemia Before Kidney Transplantation: Time for a Reappraisal. J Am Coll Cardiol. 2021 07 27; 78(4):362-364.
-
Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data? Int J Cardiol. 2020 02 01; 300:45-46.
-
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004945.
-
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation. Rev Esp Cardiol (Engl Ed). 2019 Mar; 72(3):192-194.
-
Optogenetic Modulation of Cardiac Sympathetic Nerve Activity to Prevent Ventricular Arrhythmias. J Am Coll Cardiol. 2017 Dec 05; 70(22):2778-2790.
-
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry. Catheter Cardiovasc Interv. 2017 Jun 01; 89(7):E217-E225.
-
Dietary omega-6 fatty acid replacement selectively impairs cardiac functional recovery after ischemia in female (but not male) rats. Am J Physiol Heart Circ Physiol. 2016 09 01; 311(3):H768-80.
-
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. Am J Cardiol. 2016 Jun 15; 117(12):1877-83.